Clinical trait-connected network analysis reveals transcriptional markers of active psoriasis treatment with Liangxue-Jiedu decoction

Ya-Jun Li,Tao Zhou,Jing Zhang,Lei Zhang,Hai Ke,Cang Zhang,Ping Li,Ya-jun Li
DOI: https://doi.org/10.1016/j.jep.2020.113551
IF: 5.195
2021-03-01
Journal of Ethnopharmacology
Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Psoriasis is a complex recurrent inflammatory skin disease with different pathological changes in different stages. Psoriasis in its active stage, which is comparable to the blood-heat type in traditional Chinese medicine (TCM), has been treated by Liangxue Jiedu Decoction (LJD) in TCM for decades, with proven efficacy. According to TCM theories, LJD has the function of removing heat and pathogenic factors from the blood.AIM OF THE STUDY: We aimed to investigate the molecular features associated with the active stage psoriasis and identify genes responding to LJD treatment accompanied by lesion remission.MATERIALS AND METHODS: Healthy volunteers and psoriasis patients who met specific diagnostic criteria were recruited. Twenty-six transcriptomes were profiled from the peripheral blood mononuclear cells (PBMCs) of 10 psoriasis patients (pre- and post-treatment) and 6 healthy volunteers. RNA sequencing data were analyzed using an integrated approach combining differential gene expression analysis (DGEA) and weighted gene co-expression network analysis (WGCNA), by which gene expression was linked to multiple clinical traits, including psoriasis area and severity index (PASI), as well as the improvement rate of skin lesions (ΔPASI). The actions of LJD were then verified using an in vitro cell assay coupled to flow cytometric analysis and RT-PCR.RESULTS: We identified four network modules with statistical significance (P &lt; 0.05), two of which connected to the PASI score, while the other two connected to 8-week treatment and ΔPASI, respectively. In psoriasis patients, activated inflammatory pathways and inhibited G-protein signaling genes (GTPase IMAP family member and G protein-coupled receptor) co-occurred, with high expression of CD83 and CD69, and low expression of CD160 and CD180, compared with the health. Accompanying LJD treatment and lesion remission, the expression of CD69 and cell cycle-related genes, including CCNA2, CCNB2, CDK1, and TOP2A, was down-regulated. The inhibitory role of LJD on CD69 expression was confirmed by the decline of activating naïve CD4<sup>+</sup> T lymphocytes.CONCLUSION: Our study suggests that active psoriasis is characterized by unbalanced immune status with dendrite cell and lymphocyte-associated inflammatory activation as well as NK cell- and B cell-associated defense response aberrance. LJD played an inhibitory role in T cell activation, a process located downstream pathological cascade of psoriasis.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
What problem does this paper attempt to address?
### What problem does this paper attempt to solve? This paper aims to reveal the transcriptional markers of Liangxue-Jiedu decoction (LJD) in the treatment of active psoriasis through clinical feature-related network analysis. **Specific objectives include:** 1. **Exploring the molecular characteristics of active psoriasis (blood-heat type)**: Identifying gene expression changes related to the blood-heat syndrome. 2. **Identifying genes responsive to LJD treatment**: Investigating gene expression changes accompanying lesion remission. 3. **Validating the mechanism of action of LJD**: Verifying the effect of LJD on specific gene expression through in vitro cell experiments. **Research background:** - Psoriasis is a complex recurrent inflammatory skin disease with different pathological changes at different stages. - In active psoriasis, traditional Chinese medicine considers it equivalent to the "blood-heat type," traditionally treated with Liangxue-Jiedu decoction (LJD), which has shown significant efficacy. - The study hopes to reveal the molecular mechanisms of LJD treatment from a systems biology perspective by combining differential gene expression analysis (DGEA) and weighted gene co-expression network analysis (WGCNA).